Erratum: Bisphenol-A Impairs Insulin Action and Up-Regulates Inflammatory Pathways in Human Subcutaneous Adipocytes and 3T3-L1 Cells (PLoS ONE 8: 12 (e82099) DOI: 10.1371/journal.pone.0082099);Bisphenol-A impairs insulin action and up-regulates inflammatory pathways in human subcutaneous adipocytes and 3T3-L1 cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Valentino, Rossella ^a   D'Esposito, Vittoria ^b   Passaretti, Federica ^b,c   Liotti, Antonietta ^b,c   Cabaro, Serena ^b   Longo, Michele ^b   Perruolo, Giuseppe ^a   Oriente, Francesco ^b   Beguinot, Francesco ^a,b   Formisano, Pietro ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ADIPOCYTE; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INSULIN LIKE ACTIVITY; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; PROTEIN PHOSPHORYLATION; SUBCUTANEOUS FAT;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BENZHYDRYL COMPOUNDS; CELL DIFFERENTIATION; DOWN-REGULATION; GLUCOSE; HUMANS; INFLAMMATION; INSULIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEPTIN; MICE; NF-KAPPA B; PHENOLS; PHOSPHORYLATION; RECEPTOR, INSULIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUBCUTANEOUS FAT; UP-REGULATION;

EID: 84891917490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0264656     Document Type: Erratum

References (57)

1. Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 356: 213-15. (Pubitemid 46143224)
2. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM (2010) Prevalence of high body mass indexin US children and adolescents, 2007-2008. JAMA 303: 242-49.
3. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072. (Pubitemid 43113437)
4. Ritchie SA, Connell JM (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17: 319-326. (Pubitemid 46551691)
5. Hursting SD, Dunlap SM (2012) Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue. Ann N Y Acad Sci 1271: 82-7.
6. D'Esposito V, Passaretti F, Hammarstedt A, Liguoro D, Terracciano D, et al. (2012) Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia 55(10): 2811-2822.
7. Hummasti S, Hotamisligil GS (2010) Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes. Circ Res107(5): 579-591.
8. Shapiro H, Lutaty A, Ariel A (2011) Macrophages, Meta-inflammation, and immuno-metabolism. Scientific World Journal 11: 2509-2529.
9. Gregor MF, Hotamisligil GS (2011) Inflammatory Mechanisms in Obesity. Ann Rev Immunol 29: 415-445.
10. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med18: 363-374.
11. Newbold RR, Padilla-Banks E, Jefferson WN, Heildel JJ (2008) Effects of endocrine disruptors on obesity. Int J Androl 31: 201-208.
12. Lee DH, Lee IK, Jin SH, Steffes M, Jacobs DR (2007) Association Between Serum Concentrations of Persistent Organic Pollutants and Insulin Resistance Among Non diabetic Adults: results from the National Health and Nutrition Examination Survey 1999. Diabetes Care30: 622-628. (Pubitemid 46354344)
13. Lee DH, Lee IK, Steffes M, Jacobs DR (2007) Extended Analyses of the Association Between Serum Concentrations of Persistent Organic Pollutants and Diabetes. Diabetes Care 30: 1596-1598. (Pubitemid 46871181)
14. Müllerová D, Kopecky J (2007) White Adipose Tissue: Storage and Effector Site for Environmental Pollutants. Physiol. Res. 56: 375-381.
15. Neel BA, Sargis RM (2011) The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic. Diabetes 60: 1838-1848.
16. Elobeid AM, Allison DB (2008) Putative Environmental-Endocrine Disruptors and Obesity: A Review. Curr Opin Endocrinol Diabetes Obes 15: 403-408.
17. Hatch EE, Nelson J W, Qureshi MM, Weinberg J, Moore LL, et al. (2008) Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 7: 27.
18. Everett CJ, Frithsen I, Player M (2011) Relationship of polychlorinated biphenyls with type 2 diabetes and hypertension. J Environ Monit 13: 241-51.
19. Carpenter DO (2008) Environmental contaminants as risk factors for developing diabetes. Rev Environ Health 23: 59-74. (Pubitemid 351644508)
20. Grün F, Blumberg B (2007) Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord 8: 161-171. (Pubitemid 47434649)
21. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN (2005) Developmental Exposure to Estrogenic Compounds and Obesity. Birth Defects Res A Clin Mol Teratol. (Part A). 73: 478-480. (Pubitemid 41045293)
22. Rubin BS, Soto AM (2009) Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol 304: 55-62.
23. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV (2007) Human exposure to bisphenol A (BPA). Reprod Toxicol 24: 139-177. (Pubitemid 47385100)
24. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, et al. (2009) Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environ Health Perspect 117: 1549-1555.
25. Carwile JL, Michels KB (2011) Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 111: 825-830.
26. Rubin BS (2011) Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127: 27-34.
27. Muncke J (2009) Exposure to endocrine disrupting compounds via the food chain: Is packaging a relevant source? Sci Total Environ 407: 4549-4559.
28. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, et al. (2012) Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Cien Saude Colet 17: 407-34.
29. Szymański A, Rykowska I, Wasiak W (2006) Determination of bisphenol-a in water and milk by micellar liquid chromatography. Acta Chromatograph 17: 161-172.
30. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A (2006) The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114: 106-112. (Pubitemid 43056876)
31. Makaji E, Raha S, Wade MG, Holloway AC (2011) Effect of environmental contaminants on Beta cell function. Int J Toxicol 30: 410-8.
32. Ropero AB, Alonso-Magdalena P, García-García E, Ripoll C, Fuentes E, et al. (2008) Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 31: 194-200.
33. Caruso M, Miele C, Formisano P, Condorelli G, Bifulco G, et al. (1997) In skeletal muscle, glucose storage and oxidation are differentially impaired by the IR1152 mutant receptor. J Biol Chem 272: 7290-7297. (Pubitemid 27166437)
34. Valentino R, Lupoli GA, Raciti GA, Oriente F, Farinaro E, et al. (2006) The PEA15 gene is overexpressed and related to insulin resistance in healthy firstdegree relatives of patients with type 2 diabetes. Diabetologia 49: 3058-3066. (Pubitemid 44730310)
35. Botta G, Perruolo G, Libertini S, Cassese A, Abagnale A, et al. (2010) PED/ PEA-15 modulates coxsackie virus-adenovirus receptor expression and adeno-viral infectivity via ERK-mediated signals in glioma cells. Hum Gene Ther. 21: 1067-76.
36. vomSaal FS, Hughes C(2005). An extensive new literature concerning low-dose effects of bisphenol-A shows the need for a new risk assessment. Environ Health Perspect 113: 926-933. (Pubitemid 41149619)
37. Isakson P, Hammarstedt A, Gustafson B, Smith U (2009) Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factoralpha, and inflammation. Diabetes 58: 1550-1557.
38. Calippe B, Douin-Echinard V, Delpy L, Laffargue M, Lélu K, et al. (2010) 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J Immunol 185: 1169-1176.
39. Rogers JA, Metz L, Yong VW (2013) Review: Endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Mol Immunol 53: 421-430.
40. Bernal AJ, Jirtle RL (2010) Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res A Clin Mol Teratol 88: 938-944.
41. Ben-Jonathan N, Hugo ER, Brandebourg TD (2009) Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol 304: 49-54.
42. Wadia PR, Cabaton NJ, Borrero MD, Rubin BS, Sonnenschein C, et al. (2013) Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland. PLoS One 8: e63902.
43. Siracusa MC, Overstreet MG, Housseau F, Scott AL, Klein SL (2008) 17betaestradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 180: 1423-1431.
44. Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, et al.(2004) Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 141: 209-214. (Pubitemid 38250890)
45. Kidani T, Kamei S, Miyawaki J,Aizawa J, Sakayama K, et al. (2010) Bisphenol A downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes. J Atheroscler Thromb 17: 834-843.
46. Hyun E, Ramachandran R, Hollenberg MD, Vergnolle N (2011) Mechanisms behind the anti-inflammatory actions of insulin. Crit Rev Immunol 31: 307-40.
47. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, et al. (1996) Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes. 45: 1435-8. (Pubitemid 26332910)
48. Russell CD, Petersen RN, Rao SP, Ricci MR, Prasad A, et al. (1998) Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone. Am J Physiol 275: E507-E515.
49. Sargis RM, Johnson DN, Choudhury RA, Brady MJ (2010) Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring)18: 1283-1288.
50. Golub MS, Wu KL, Kaufman FL, Li LH, Moran-Messen F, et al. (2010) Bisphenol A: developmental toxicity from early prenatal exposure. Birth Defects Res B Dev Reprod Toxicol. 89: 441-466.
51. Wei J, Lin Y, Li Y, Ying C, Chen J, et al. (2011) Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology 152: 3049-3061.
52. Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ, et al. (2010) Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology 151: 2603-2612.
53. Miao M, Yuan W, Zhu G, He X, Li DK (2011) In utero exposure to bisphenol- A and its effect on birth weight of offspring. Reprod Toxicol 32: 64-68.
54. Tilg H, Moschen AR (2008) Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14: 222-31. (Pubitemid 351481853)
55. Shankar A, Teppala S (2011) Relationship between urinary bisphenol A levels and diabetes mellitus. J Clin Endocrinol Metab 96: 3822-6.
56. Silver MK, O'Neill MS, Sowers MR, Park SK (2011) Urinary bisphenol A and type-2 diabetes in U.S. adults: data from NHANES 2003-2008. PLoS One 6: e26868.
57. Tarantino G, Valentino R, Di Somma C, Orio F, Pivonello C, et al. (2012) Bisphenol-A in Polycystic Ovary Syndrome and its association with liver-spleen axis. Clin. Endocrinol (Oxf.) 78: 447-453.